✦ LIBER ✦

The role of the inferior frontal gyri in cognitive processing of patients with Parkinson's disease: A pilot rTMS study

✍ Scribed by Hana Srovnalova; Radek Marecek; Irena Rektorova

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 565 KB
Volume: 26
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.23663

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Controlled pilot study of the effects of

Controlled pilot study of the effects of neuromuscular therapy in patients with Parkinson's disease

✍ Lauren H. Craig; Anna Svircev; Michael Haber; Jorge L. Juncos 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

## Abstract The objectives of this study is to examine the effects of neuromuscular therapy (NMT) on motor and nonmotor symptoms in Parkinson's disease (PD). Thirty‐six subjects with PD were randomly assigned to NMT or music relaxation (MR, or active control). Subjects received treatment twice a we

Localized proton NMR spectroscopy in the

Localized proton NMR spectroscopy in the striatum of patients with idiopathic parkinson's disease: a multicenter pilot study

✍ Barbara A. Holshouser; Markku Komu; Harald E. Möller; Jan Zijlmans; Heinrich Kol 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 641 KB

Single voxel proton MRS was used to study brain metabolism in the striatum of patients diagnosed with idiopathic Parkinson's disease (PD). Peak metabolite ratios in long echo time spectra were evaluated in 151 patient spectra and 97 age-matched control spectra collected at four participating institu

Open-label flexible-dose pilot study to

Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease

✍ Joseph H. Friedman; Robert M. Berman; Christopher G. Goetz; Stewart A. Factor; W 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 2 views

## Abstract Psychosis affects at least 5% to 8% of medication‐treated patients with idiopathic Parkinson's disease (PD). Treatment options include reducing medications used for the treatment of PD‐related motor symptoms or introducing an atypical antipsychotic drug. Only clozapine has been demonstr

The effects on cognitive functions of a

The effects on cognitive functions of a movement-based intervention in patients with Alzheimer's type dementia: a pilot study

✍ Lidia Yágüez; Kendra N. Shaw; Robin Morris; David Matthews 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 303 KB 👁 2 views

To explore the effect of a non-aerobic movement based activity on cognition in people with Alzheimer's type dementia (AD). Methods: The sample consisted of 27 patients fulfilling the AD ICD-10 diagnostic criteria. The patient sample was randomly divided into two groups: The Exercise Group received 6

The effects of rasagiline on cognitive d

The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double-blind, placebo-controlled, multicenter study

✍ Hasmet A. Hanagasi; Hakan Gurvit; Pınar Unsalan; Hilal Horozoglu; Nese Tuncer; A 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

## Abstract Cognitive impairment can occur at all stages of Parkinson's disease. Rasagiline is a selective monoamine oxidase type‐B inhibitor that enhances central dopaminergic transmission. Dopamine is thought to be involved in certain cognitive processes such as working memory. We assessed the ef

A pilot evaluation of the tolerability,

A pilot evaluation of the tolerability, safety, and efficacy of tolcapone alone and in combination with oral selegiline in untreated Parkinson's disease patients

✍ Robert A. Hauser; Eric Molho; Heidi Shale; Simon Pedder; Ernest E. Dorflinger 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 489 KB

## Abstract Tolcapone is a potent, reversible catechol‐O‐methyltransferase (COMT) inhibitor with both peripheral and central activity. It has been demonstrated to improve motor function and allow levodopa dose reductions in Parkinson's disease (PD) patients who are experiencing either a stable resp